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Solid pseudopapillary neoplasm (SPN) of the pancreas is a rare tumor presenting in adolescent and
young adult females. A previously healthy 13 year-old female presented to our institution with
abdominal pain and emesis. Imaging revealed a pancreatic cystic mass. Endoscopic ultrasound (EUS)
with ﬁne needle biopsy suggested SPN. Pathologic evaluation following resection revealed immuno-
histochemical (IHC) staining positive for b-catenin and a-1-antitrypsin despite extensive necrosis. We
discuss this patient as well as our institutional series of SPN of the pancreas, describing the evaluation,
management, and histopathology of this rare tumor.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Solid pseudopapillary neoplasm (SPN) of the pancreas is an
uncommon tumor of the exocrine pancreas, occurring predomi-
nantly in young females [1,2]. Unlike other forms of pancreatic
neoplasm, SPN of the pancreas demonstrates an excellent long-
term prognosis with adequate resection [3,4]. With accurate pre-
operative diagnosis, surgical planning and intraoperative decision
making are enhanced.
We present a case of SPN of the pancreas in which the diagnosis
was suggested after ﬁne-needle aspiration cytology on endoscopic
ultrasound. Deﬁnitive diagnosis was made from immunohisto-
chemical (IHC) staining, which allowed for appropriate surgical
planning and adequate resection. Without IHC staining, the
extensive necrosis on endoscopic biopsy would have resulted in an
otherwise indeterminate diagnosis, demonstrating the importance
of this histologic evaluation. We also present a single-institutional
case series of patients undergoing resection for SPN of the pancreas,gery, Nationwide Children’s
USA. Tel.: þ1 614 722 0440;
ns.org (J.H. Aldrink).
c. This is an open access article underevealing additional pediatric patients for whom immunochem-
istry was valuable in establishing their diagnosis.1. Case report
A 13-year old previously healthy female presented to our
emergency department with a three day history of abdominal pain,
emesis, and malaise. Physical exam revealed mild right-sided
abdominal tenderness. A limited right lower quadrant abdominal
ultrasound was unremarkable, therefore a computed tomography
(CT) scan was obtained demonstrating a predominantly cystic
structure arising from the duodenum and abutting the pancreatic
head, without biliary or pancreatic ductal dilation (Fig. 1).
Carcinoembryonicantigen(CEA)andcancerantigen (CA)19-9were
not elevated.Magnetic resonance imaging (MRI) further characterized
the lesion as a peripherally enhancing round lesion insinuated be-
tween the pancreatic head and second portion of the duodenum,
(Fig.2) suggestiveof eitheraduplicationcystwith internalhemorrhage
or a solid pancreatic head mass. She then underwent endoscopic ul-
trasonography (EUS) which revealed that this cystic mass was heter-
ogenous in nature and without evidence of internal vascular ﬂow
(Fig. 3). Fine needle aspiration revealed monomorphic necrotic cellsr the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Axial (A) and coronal (B) computed tomographic images of the intra-abdominal cystic mass at diagnosis.
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enin and weakly reactive for synaptophysin and chromogranin.
Given these ﬁndings, the patient underwent exploratory lapa-
rotomy via a bilateral subcostal incision. A 3 cm mass arising from
the head of the pancreas and adherent to the second portion of the
duodenumwas identiﬁed (Fig. 4). A pancreaticoduodenectomy was
performed for complete resection. The pancreatic duct was not
dilated, measuring approximately 2e3 mm. Visceral reconstruction
was achieved with hepaticojejunostomy, pancreaticojejunostomy,
and gastrojejunostomy.
On pathological examination, the mass was an encapsulated
3  3  2.5 cm lesion arising from the head of the pancreas. The cut
surface showed yellow brown necrotic tissue with gritty yellow
calciﬁed material. Microscopically, the lesion had a large amount of
necrosis with focal areas of neoplastic cells, characterized by small to
mediumsizedcellsmostly in sheets.Within thenecrotic areas, ghosts
of papilliform structureswere present (Fig. 5). On IHC, the tumorwas
positive for b-catenin and a-1-antitrypsin. Testing for CD10 was
indeterminate, and the tumor was not tested for e-cadherin.
The patient’s postoperative recovery was complicated by pro-
longed gastroparesis. She received total parenteral nutrition for two
weeks and subsequent nasojejunal feedingwhichwas discontinued
once she tolerated oral intake. This ultimately resolved and her
postoperative course was otherwise uncomplicated. Final histopa-
thology demonstrated this lesion to be a solid pseudopapillary
neoplasm of the pancreas with extensive necrosis and negative
margins. Follow-up imaging has demonstrated no evidence of
recurrence at 1 year from resection. Given complete resection,
adjuvant therapy was not indicated.
Following this case, a review ofmedical and pathological records
at our institution, revealed eight patients between January 1995Fig. 2. A) Axial T2-weighted image of the cystic mass (M) with delineation of the plane b
demonstrating its heterogeneity and encapsulation.and December 2014 who were treated for SPN of the pancreas
(Table 1). Three of the patients demonstrated intralesional necrosis
on histopathology. All eight patients were female and none
required adjuvant therapy following resection. With a median
follow up time of 5 years (range 1e5 years), there were no re-
currences. There was one death that was unrelated to the diagnosis
or treatment of SPN of the pancreas.
2. Discussion
SPNs of the pancreas are neoplasms of low malignant potential
found predominantly in young females [1,2]. They account for 1e2%
of all exocrine pancreatic tumors [5], but 52e71% of pancreatic
tumors in children and adolescents [6,7]. The etiology is unknown
but suspected to be genetically distinct from pancreatic ductal
neoplasms [2]. Despite their preferential association with young
women, there are no reports suggesting an association with
endocrine disturbances [8]. These tumors do not demonstrate a
preferential localization within the pancreas. These neoplasms are
often found incidentally on routine physical examination or in pa-
tients who present with abdominal pain [9,10]. As in our patient
and our institutional review, they are not often associated with
pancreatic ductal dilation [11,12].
The differential diagnosis for SPN includes pancreatic pseudo-
cysts, duplication cysts, and other neoplasms of the pancreas
including lymphoma and cystic neoplasms [13,14]. Pathology often
reveals lobulated solid areas with zones of hemorrhage and ne-
crosis, and cystic spaces ﬁlled with necrotic debris [9,15]. IHC is
useful for diagnosis of SPN of the pancreas [9]. Positive markers for
a-1-antitrypsin, a-1-antichymotrypsin, phospholipase A2, CD 10,
and CD 56 are suggestive of pancreatic lesions [16]. A combinationetween the mass and the duodenum (D). B) Coronal T2-weighted image of the mass,
Fig. 3. Endoscopic ultrasonographic imaging of intra-abdominal mass, marked with
dotted lines.
Fig. 4. Surgical resection specimen with the antrum, duodenum, and pancreatic head
mass (3  3  2.5 cm).
Fig. 5. A) Hematoxylin-eosin staining of the lesion at 100 magniﬁcation. Sheets of
small to medium-sized, relatively uniform lesional cells growing in an inﬁltrative sheet
are present in the upper portion with normal pancreatic islands of acini in the lower
half. A group of normal ductules separate the lesion (L) from normal (N). B) Immu-
nohistochemical staining for b-catenin at 100 magniﬁcation. Strong, diffuse nuclear
staining in lesional cells within a necrotic area is noted.
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for SPN when compared to other pancreatic neoplasms [2,17e19].
Unlike pancreatic adenocarcinoma and neuroendocrine carcinoma,
patients do not typically demonstrate elevated CEA or CA 19-9 [20].
Due to these staining characteristics, ﬁne-needle aspiration
(FNA) cytology is frequently helpful for making a diagnosis preop-
eratively [21]. However, FNA is rarely used in pediatric patients
[10,22,23]. EUS-FNA demonstrates improved sensitivity for diag-
nosing SPN of the pancreas in adults, correctly identifying over 80%
of patients with SPN [11]. In the present case, FNA revealed necrotic
laminar cells typical in large neoplasms (>5 cm) and nondiagnostic
when found in isolation, but the diagnosis was still strongly sus-
pected by IHC. Our institutional case series includes several patients
for whom histopathology revealed central hemorrhage and ne-
crosis (Table 1). Others have also reported SPN of the pancreas with
extensive cellular degeneration [24].
Complete surgical resection is the treatment of choice when
feasible. In this case, a pancreaticoduodenectomy was performed
given the location of the lesion at the head of the pancreas. Other
options for treatment include enucleation or subtotal pancreatec-
tomy, depending on location of the tumor. Making a correct intra-
operative diagnosis is important because of the comparatively
improved prognosis of SPN as compared to other pancreatic
Table 1
Institutional review of patients with SPN of the pancreas.
Age Surgery Pathology Immunohistochemistry Patient status
16 Spleen-preserving distal
pancreatectomy
4  6 cm solid mass of the pancreas,
hemorrhagic center, negative margins.
No pancreatic ductal dilation.
No immunohistochemistry performed. NED
11 Pancreatoduodenectomy 14  11  9 cm mass at head of pancreas,
hemorrhagic center, negative margins.
No immunohistochemistry performed. NED
14 Pancreatoduodenectomy 4.2 cm mass in the head of the pancreas,
necrotic and hemorrhagic, negative margins.
No pancreatic ductal dilation.
Positive: vimentin & NSE.
Negative: synaptophysin, keratins and
chromogranin.
NED
15 Spleen-preserving distal
pancreatectomy
7.8  4.6  3.2 cm encapsulated mass with
negative clear margins.
Positive: NSE.
Negative: synaptophysin, keratins and
chromogranin.
NED
14 Pancreatoduodenectomy 2.5  1.5  1.2 cm mass with pseudopapillary
architecture and areas of hemorrhage and necrosis.
No immunohistochemistry performed. NED
13 Pancreatoduodenectomy 3 cm encapsulated mass with pseudopapillary
architecture, extensive necrosis, and negative
margins. No pancreatic ductal dilation.
Positive: vimentin, b-catenin, and
a-1-antitrypsin.
Negative: synaptophysin and chromogranin.
NED
15 Distal spleen-preserving
pancreatectomy
7  6  6 cm encapsulated mass, with central
necrosis and positive margins. No pancreatic
ductal dilation.
Positive: NSE and a-1-antitrypsin. Death 3 months
after surgery from
respiratory complications
of primary illness.
15 Pancreatoduodenectomy,
pylorus preserving
5  4  2.8 cm cystic structure, encapsulated,
negative margins. No pancreatic ductal dilation.
Positive: NSE, b-catenin, and a-1-antitrypsin.
Negative: chromogranin.
NED
NSE: Neuron-speciﬁc enolase. NED: No evidence of disease.
Median follow-up was 5 years (range 1 yeare5 years). All patients were female.
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dergo pylorus-preserving pancreatoduodenectomy or spleen-pre-
serving distal pancreatectomy. None of the patients in our case
series required adjuvant treatment.
Prognosis of SPN of the pancreas following complete resection
with negative margins is excellent. Reports suggest that these
neoplasms grow slowly, and recurrence is uncommon following
complete resection. Although methods of treatment involving
chemoradiation, radiofrequency ablation and HIPEC have been
described, repeat surgical resection is warranted should they recur
[3,26e28]. These various adjuvant techniques have all been applied
to adult patients who presented with overwhelming metastasis.
Pediatric patients reported in the current literature have typically
presentedwith resectable disease, with an overall ﬁve-year survival
of 95% [3,4].
3. Conclusion
Although SPN of the pancreas is a rare form of pancreatic
neoplasm, pediatric patients with pancreatic neoplasms are more
likely to have SPN than other diagnoses. The diagnosis may be
difﬁcult to make preoperatively, but EUS-FNA and IHC are
frequently helpful. With complete surgical resection, patients can
expect an excellent prognosis.
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